| |
All patients (n=94)
|
Patients with Cp >17.5 (n=72)
|
Patients with Cp <17.5 (n=22)
|
P-value for comparison
|
|---|
|
Female
|
35 (37%)
|
26 (36%)
|
9 (41%)
|
0.80
|
|
Age, years
|
74 (14-96)
|
69 (25-96)
|
74 (14-93)
|
0.36
|
|
Co-morbidities
| | | | |
|
Heart disease
|
22 (23%)
|
14 (20%)
|
8 (36%)
|
0.12
|
|
Neurological disease
|
13 (14%)
|
8 (11%)
|
5 (23%)
|
0.18
|
|
Chronic renal failure
|
12 (13%)
|
10 (14%)
|
2 (9%)
|
0.54
|
|
Neoplasms
|
17 (18%)
|
14 (20%)
|
3 (14%)
|
0.50
|
|
Clinical data
| | | | |
|
Antibiotics before analyses
|
20 (21%)
|
15 (21%)
|
5 (23%)
|
0.85
|
|
Blood culture positivity
|
45 (48%)
|
23 (32%)
|
22 (100%)
|
<0.001
|
|
C-reactive protein
|
108 (1-446)
|
93 (1-372)
|
212 (12-446)
|
0.002
|
|
Body temperature, C°
|
38.7 (37.0-41.4)
|
38.7 (37.1-41.0)
|
38.8 (37.0-41.4)
|
0.89
|
|
> 2 SIRS criteria
|
82 (87%)
|
61 (85%)
|
21 (96%)
|
0.19
|
|
Severe sepsis/septic shock
|
27 (29%)
|
11(15%)
|
16 (73%)
|
<0.001
|
|
Septic shock
|
3 (3%)
|
0
|
3 (14%)
|
0.01
|
|
Hospitalisation length, days
|
7 (0-78)
|
5 (0-75)
|
19.5 (4-78)
|
<0.001
|
|
Intensive care unit admission
|
8 (9%)
|
3 (4%)
|
5 (23%)
|
0.016
|
|
1 month mortality rate
|
8 (9%)
|
4 (6%)
|
4 (18%)
|
0.084
|
- Data are presented as numbers (percentages) for categorical variables and as median values (ranges) for continuous variables.
